Journal List > Dement Neurocogn Disord > v.11(2) > 1120805

Dement Neurocogn Disord. 2012 Jun;11(2):74-77. Korean.
Published online Jun 30, 2012.
Copyright© 2012 Korean Dementia Association
A Case of Familial Creutzfeldt-Jacob Disease (V180I) Initially Presenting with Depression
JaeJeong Joo, M.D., YoungSoon Yang, M.D., Jin Ho Kang, M.D., Sun Hwa Lee, M.D., Sang Won Ha, M.D., Jung Ho Han, M.D., Eun Kyung Cho, M.D. and Doo Eung Kim, M.D.
Department of Neurology, Veterans hospital, Seoul Medical Center, Seoul, Korea.

Address for correspondence: Young Soon Yang, M.D. Department of Neurology, Veterans Hospital, Seoul Medical Center, 6-2 Dunchon 2-dong, Gangdong-gu, Seoul 134-791, Korea. Tel: +82-2-2225-4106, Fax: +82-2-2225-4105, Email:
Received Jun 12, 2012; Revised Jun 22, 2012; Accepted Jun 22, 2012.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Creutzfeldt-Jakob disease (CJD) is a degenerative neurological disorder that is incurable and invariably fatal. It is characterized by rapidly progressive dementia presenting with memory loss, personality changes and hallucinations. The symptoms of CJD are caused by progressive death of neurons in the central nervous system, which is associated with build-up of the abnormal prion proteins forming amyloids. In human, CJD can be acquired genetically through a mutation of the gene encoding for the prion protein (PRNP). This occurs in only 5-10% of all CJD cases. We report a 64-year old woman with CJD carrying a V180I mutation that features late onset, rapid progression, no periodic sharp wave complexes on electroencephalography, and cortical signal change and edema in bilateral frontotemporoparietal lobes and basal ganglia on MRI.

Keywords: Creutzfeldt-Jakob disease; Prion protein; V180I mutation


Fig. 1
Diffusion weighted MR images show cortical signal change and edema in both frontotemporoparietal lobes and both basal ganglia. Both cerebellum and occipital lobes are spared.
Click for larger image

Fig. 2
T2 weighted MRI also shows cortical signal change and edema in both frontotemporoparietal lobes and both basal ganglia. Both cerebellum and occipital lobes are spared.
Click for larger image

Fig. 3
Brain PET-CT shows marked hypometabolism in bilateral cerebral hemispheres with sparing of the occipital regions and primary motor sensory cortices.
Click for larger image

Fig. 4
MR spectroscopy shows decreased NAA peak and increased choline peak in both frontotemporoparietal lobes and both basal ganglia.
Click for larger image

Fig. 5
EEG shows intermittent theta-to-delta range slow waves in both cerebral hemispheres.
Click for larger image

Fig. 6
(A) DNA sequence at codon 180 of the PRNP gene from the patient (left) and a normal control (right). There is a point mutation causing a substitution of GTC(Val) by ATC(Ile) at codon 180. (B) Homozygosity for methionine at codon 129 and homozygosity for glutamate at codon 219 are also identified in the sequence analysis of the PRNP gene mutation of the patient.
Click for larger image

1. Rabinovici GD, Wang PN, Levin J, Cook L, Pravdin M, Davis J, et al. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology 2006;66:286–287.
2. Heinemann U, Krasnianski A, Meissner B, Grasbon-Frodl EM, Kretzschmar HA, Zerr I. Novel PRNP mutation in a patient with a slow progressive dementia syndrome. Med Sci Monit 2008;14:CS41–CS43.
3. Kong QK, Surewicz WK, Petersen RB, Zhou W, Chen SG, Gambetti P, et al. Inherited Prion Diseases. In: Prusiner SB, editor. Prion Biology and Disease. 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2004. pp. 673-776.
4. Zerr I, Poser S. Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests. APMIS 2002;110:88–98.
5. World Health Organization. WHO Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: Report of a WHO consultation; Emerging and other communicable diseases, surveillance and control. 1998 Feb. pp. 9-11.
6. Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004;63:443–449.
7. Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005;26:1551–1562.
8. Yamada M. Prion diseases in Japan: analysis of 918 patients. Rinsho Shinkeigaku 2007;47:805–808.
9. Chasseigneaux S, Haik S, Laffont-Proust I, De Marco O, Lenne M, Brandel JP, et al. V180I mutation of the prion protein gene associated with atypical PrPSc glycosylation. Neurosci Lett 2006;408:165–169.
10. Nixon R, Camicioli R, Jamison K, Cervenakova L, Mastrianni JA. The PRNP-V180I mutation is associated with abnormally glycosylated PrP-CJD and Intracellular PrP accumulations. Presented at XIVth International Congress of Neuropathology Scientific Programme. Brain Pathology 2000;10:670.
11. Jin K, Shiga Y, Shibuya S, Chida K, Sato Y, Konno H, et al. Clinical features of Creutzfeldt-Jakob disease with V180I mutation. Neurology 2004;62:502–505.
12. Yang TI, Jung DS, Ahn BY, Jeong BH, Cho HJ, Kim YS, et al. Familial Creutzfeldt-Jacob Disease with V180I Mutation. J Korean Med Sci 2010;25:1097–1100.